Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 336,456 | 336,199 | 455,513 | 670,952 | 729,685 |
| Marketable Securities | 254,113 | 287,151 | 231,736 | 178,951 | 152,677 |
| Receivables | 34,195 | 27,937 | 25,207 | 26,101 | 22,561 |
| TOTAL | $696,608 | $717,773 | $737,612 | $893,269 | $913,777 |
| Non-Current Assets | |||||
| PPE Net | 9,435 | 8,580 | 7,856 | 7,768 | 7,621 |
| Investments And Advances | 61,950 | 89,194 | 108,193 | 7,585 | 4,999 |
| Other Non-Current Assets | 19,855 | 20,505 | 22,132 | 23,715 | 21,368 |
| TOTAL | $91,240 | $118,279 | $138,181 | $39,068 | $33,988 |
| Total Assets | $787,848 | $836,052 | $875,793 | $932,337 | $947,765 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,086 | 9,438 | 4,463 | 8,472 | 8,861 |
| Accrued Expenses | 44,122 | 42,488 | 38,074 | 44,681 | 21,917 |
| TOTAL | $57,371 | $59,478 | $49,819 | $60,163 | $37,302 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,324 | 13,540 | 15,143 | 17,067 | 15,327 |
| TOTAL | $12,324 | $13,540 | $15,143 | $17,067 | $15,327 |
| Total Liabilities | $69,695 | $73,018 | $64,962 | $77,230 | $52,629 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,156 | 60,901 | 60,699 | 60,550 | 60,252 |
| Common Shares | 61 | 61 | 60 | 60 | 60 |
| Retained earnings | -1,074,894 | -1,004,429 | -940,908 | -877,437 | -820,042 |
| Other shareholders' equity | -398 | -409 | -417 | -288 | -225 |
| TOTAL | $718,153 | $763,034 | $810,831 | $855,107 | $895,136 |
| Total Liabilities And Equity | $787,848 | $836,052 | $875,793 | $932,337 | $947,765 |